Scientech Research LLC’s BioCardia BCDA Stock Holding History

Scientech Research LLC’s Portfolio BCDA Stock Details BCDA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-1,535	Closed	-$14.9K	–	415
2023 Q4	$14.9K	Buy	+1,535	New	+$12.5K	0.01%	302

Other funds holding BCDA

CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

Family Management New York $834M AUM 20.83% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Scientech Research LLC's BCDA Position: Q1 2024 in Review

Scientech Research LLC sold out of BioCardia (BCDA) in Q1 2024, closing a stake of 1,535 shares — an estimated $14.9K sold.

Scientech Research LLC first reported a position in BCDA in Q4 2023 and held it in 1 quarter. The position peaked at $14.9K in Q4 2023. 22 funds tracked by Wall St. Rank hold BCDA as of Q1 2024.

Scientech Research LLC reported no remaining BioCardia position as of Q1 2024 after selling out during the quarter.
Scientech Research LLC sold 1,535 BioCardia shares in Q1 2024, an estimated $14.9K.
Scientech Research LLC first reported a position in BioCardia in Q4 2023 and held it in 1 quarter.
Scientech Research LLC's BioCardia position peaked at $14.9K in Q4 2023.
22 funds tracked by Wall St. Rank held BioCardia as of Q1 2024.

Based on Scientech Research LLC's 13F filing for Q1 2024, filed 15 May 2024.